Hudson Valley Investment Advisors Inc. ADV Has $3.75 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Hudson Valley Investment Advisors Inc. ADV boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 20,242 shares of the healthcare conglomerate’s stock after buying an additional 685 shares during the period. Hudson Valley Investment Advisors Inc. ADV’s holdings in UnitedHealth Group were worth $3,753,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. State Street Corp boosted its position in shares of UnitedHealth Group by 2.5% in the first quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock worth $7,499,276,000 after buying an additional 1,122,534 shares in the last quarter. Dodge & Cox bought a new position in UnitedHealth Group during the fourth quarter valued at $1,658,560,000. Norges Bank bought a new position in UnitedHealth Group during the fourth quarter valued at $1,530,177,000. Legal & General Group Plc boosted its position in UnitedHealth Group by 5.4% in the first quarter. Legal & General Group Plc now owns 4,954,692 shares of the healthcare conglomerate’s stock valued at $812,630,000 after buying an additional 254,545 shares during the period. Finally, Harris Associates L P boosted its position in UnitedHealth Group by 0.3% in the first quarter. Harris Associates L P now owns 4,646,307 shares of the healthcare conglomerate’s stock valued at $762,041,000 after buying an additional 14,489 shares during the period. Hedge funds and other institutional investors own 86.21% of the company’s stock.

Shares of UnitedHealth Group Incorporated (NYSE:UNH) opened at 191.78 on Friday. The firm’s 50-day moving average is $184.43 and its 200 day moving average is $171.28. UnitedHealth Group Incorporated has a 52-week low of $132.39 and a 52-week high of $193.00. The company has a market capitalization of $184.81 billion, a price-to-earnings ratio of 24.55 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.38 by $0.08. The firm had revenue of $50.05 billion for the quarter, compared to the consensus estimate of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.96 EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post $9.86 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 27th. Shareholders of record on Monday, June 19th were issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.56%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $0.63. The ex-dividend date was Thursday, June 15th. UnitedHealth Group’s payout ratio is currently 35.13%.

COPYRIGHT VIOLATION NOTICE: This news story was first published by [[site]] and is the sole property of of [[site]]. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of U.S. & international copyright legislation. The original version of this news story can be viewed at [[permalink]].

Several research analysts have recently weighed in on UNH shares. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Friday, May 19th. Deutsche Bank AG started coverage on shares of UnitedHealth Group in a report on Wednesday, April 5th. They issued a “buy” rating and a $183.00 price target for the company. Vetr upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 price target for the company in a report on Wednesday, April 5th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $200.00 price target on shares of UnitedHealth Group in a report on Thursday, April 6th. Finally, Mizuho upped their price target on shares of UnitedHealth Group from $178.00 to $200.00 and gave the company a “buy” rating in a report on Tuesday, April 18th. One research analyst has rated the stock with a hold rating and twenty-four have assigned a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $199.72.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $182.64, for a total transaction of $913,200.00. Following the transaction, the director now directly owns 75,735 shares of the company’s stock, valued at approximately $13,832,240.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Gail R. Wilensky sold 5,540 shares of UnitedHealth Group stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total transaction of $990,219.60. Following the transaction, the director now directly owns 60,516 shares in the company, valued at $10,816,629.84. The disclosure for this sale can be found here. 0.89% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).